@simoncomerma profile picture
simoncomerma @simoncomerma

World Researcher of Animal Physiology and Pharmacology, using translational models, lately of Sexual Dysfunction to evaluate vmats/ions-endot..-vascular changes

Joined June 2012
  • Tweets 189
  • Following 732
  • Followers 140
31 Photos and videos
Check on how KCa 2.2-3 channels opening could be beneficial for hypertensive - ET-1-->NLRP3 erectile dysfunction! linkedin.com/posts/simon-g-c…

A KCa 2.2/2.3 Opener Reverses ET-1-Induced NLRP3 Activation in Hypertensive Mice Corpora Cavernosa...

Nice news! Rafael Fais's article from his PhD externship at Health - Aarhus University is out! We have shown that KCa2.2-3 (#SK) channels opening in a #DOCA animal model of hypertension and erectile...

linkedin.com
42
On the effects of IP2018 over spontaneous erections in an animal model of depression. linkedin.com/posts/simon-g-c… thanks for the opportunity @essm_tweets @ISSM_INFO @AarhusUni #WMSM2026 #INIT

#init | Simon G. Comerma Steffensen

Nice time at Oporto. I finally presented data on how IP2018 will induce positive results on erectile function from control (young and adult), and an animal model of depression, and how this is...

linkedin.com
2
100
Coming with some new data on animal models for psychogenic erectile dysfunction and IP2018 for its treatment at the #ESSM and #ISSM 2026 meeting @AarhusUni @UsUlf @GregersWegener @FaisSobrano $INIT linkedin.com/posts/simon-g-c…

#essm #issm | Simon G. Comerma Steffensen

On my way to the ISSM-ESSM meeting, we will bring some presentations (Elif A., Gökay Albayrak) from Aarhus University. My presentation will be about IP2018 "IP2018, a Dual Serotonin and Dopamine...

linkedin.com
1
2
145
Nice News about the European patent approval for vulvodynia and FSD using Pudafensine at the Phase2A study to address this group of Women in need! #INIT @AarhusUni linkedin.com/posts/simon-g-c…

Initiator Pharma granted European patent for pudafensine in Female Sexual Dysfunction, including...

Awesome to hear about Pudafensine and the patent approval for vulvodynia, Sexual Dysfunction and related diseases in Europe. Also that this Phase 2A study is advancing and we can get some nice data...

linkedin.com
3
95
Happy for the phase 2A initiating enrollment for vulvodynia and FSD, possible treatment for women in need #INIT linkedin.com/posts/simon-g-c…

Initiator Pharma initiates patient enrollment in Phase IIa vulvodynia study - Initiator Pharma |...

Excited and Joyful! to see this as a Christmas gift! Initiation of patient enrollment for Phase 2A on the use of Pudafensine for Vulvodynia and Female Sexual Dysfunction! Starting in January 2026!...

linkedin.com
1
3
77
Grateful to the Asian Journal of Andrology for awarding me one of the Outstanding Reviewers of 2025! linkedin.com/posts/simon-g-c…

Asian Journal of Andrology | Simon G. Comerma Steffensen

Honored and happy to hear about the recognition from the Asian Journal of Andrology: https://lnkd.in/eCBEkuCR as one of their Outstanding Reviewers. Thanks to them, it is always nice to review for...

linkedin.com
27
Curious on how it will advance? Vulvodynia and female sexual dysfunction, linkedin.com/posts/simon-g-c…

Initiator Pharma receives UK CTA approval to initiate Phase 2a study in vulvodynia - Initiator...

Promising opportunity for women with chronically vulva pain and concomitant female sexual dysfunction! curious on how it will go!

linkedin.com
1
2
126
Thanks for the MSCA-NPC-dk for my nomination representing Denmark! COST-sex as Biological variable! linkedin.com/posts/simon-g-c…

Nice kick off meeting at COST Association - European Cooperation in Science and Technology at...

Nice kick off meeting at COST Association - European Cooperation in Science and Technology at brussels with the leading of Ivana Jaric, interesting to hear how it will developed during these next 3...

linkedin.com
35
simoncomerma retweeted
European Society for Sexual Medicine (ESSM)@essm_tweets
17 Jul 2025
🤝 Meet the ESSM Basic Science Committee – driving innovation in #SexualMedicine! 🧬 They promote research, develop content for Congresses & webinars, and bridge benchside science with clinical care. 📲Swipe up to meet the team. @omeronurcakir
1
5
17
2,117
Nice work on BPP-NH2- a peptide from an Amazonian yellow frog could give an improved relaxation by incrementing L-arginine availability for Nitric Oxide production sciencedirect.com/science/ar… @SimonsenUlf @jpratduran @AarhusUni_int @UCV_Noticias @aalborg_uni
58
Thanks to the #ESSM2025 nice opportunity to present our data on pudafensine @AarhusUni @tnu_au_dk linkedin.com/posts/simon-g-c…

#essm2025 | Simon G. Comerma Steffensen

Thanks to the European Society for Sexual Medicine - ESSM, in the #ESSM2025, I have presented some positive data on clitoral flow and behavior on female desire from Pudafensine (IPED2015). Thanks for...

linkedin.com
1
112
Nice article on bioenergetics in mitochondrial function in erectile tissue and H2O2 from a HFD metabolic syndrome diseased mouse model. @Alfonso10671630 @Anasanchezpina @dprietoocejo @UsUlf linkedin.com/posts/simon-g-c…

Penile endothelial dysfunction, impaired redox metabolism and blunted mitochondrial bioenergetics...

Happy to congratulate Alfonso Gómez del Val, PhD for his paper https://lnkd.in/ed3gWbqG just published! This is an excellent piece of information on the changes in mitochondrial bioenergetics in a...

linkedin.com
2
106
linkedin.com/posts/simon-g-c… Soon! more about pudafensine (IP2015) effects on the rodent female vasculature and over the sexual function behavior! #ESSM25 @essm_tweets @UsUlf @Geomar_Seijas @UCV_Noticias @AarhusUni

#essm25 | Simon G. Comerma Steffensen

Happy to share that I will be presenting in February in an oral presentation at the podium sessions on Basic Science the late results of the vascular and behavioural effects on sexual function of...

linkedin.com
2
3
141
linkedin.com/posts/simon-g-c… soon to discuss about Pudafensine (IP2015) effects on clitoral and pudendal blood flow in our rodent animal model positive effects towards female sexual function at @2024_ISRA Thanks for the opportunity.@AarhusUni @Geomar_Seijas @UsUlf

Happy to share, today I will be presenting some new data on IP2015 female genitalia effects in our...

Happy to share, today I will be presenting some new data on IP2015 female genitalia effects in our rodent model as a poster, and tomorrow giving a 20 min oral presentation at the ISRA24 meeting at...

linkedin.com
1
3
101
Support for Ataxia of Friedreich inspiring story, hear 1:24 h and on! youtube.com/live/cWe3jo1J-Rw look for QR code, is in Portuguese!

V INOVATEC | DIA 3 (24/11/2024) | PALCO INOVATEC

O V Encontro Internacional de Inovação em Saúde – V INOVATEC será r...

youtube.com
109
Nice presentations at inovatec in Brasilia linkedin.com/posts/simon-g-c… @AarhusUni @RtUCVnoticias

V INOVATEC | DIA 3 (24/11/2024) | PALCO INOVATEC | Simon G. Comerma Steffensen

Excellent days for https://inovatecdf.com.br/ meeting day1 https://lnkd.in/e_6rZ8VF  , day2 https://lnkd.in/ehYYkGbP  (check for my presentation 1:40 h "spoiler in Spanish", day3 https://lnkd.in/eF...

linkedin.com
77
On my way for some scientific discussions linkedin.com/posts/simon-g-c… #innovatec24

#science #innovatec | Simon G. Comerma Steffensen

On my way to the innovation https://inovatecdf.com.br/ meeting in Brasilia, Brazil. Thanks JOSE ROBERTO DE SOUZA DE LEITE and Andreanne Gomes Vasconcelos for the current invitation, and previous year...

linkedin.com
2
109
simoncomerma retweeted
Ernesto Schiffrin@ESchiffrin
17 Oct 2024
Geographical Differences in Hydrochlorothiazide Associated Risk of Skin Cancer Balanced Against Disability Related to Hypertensive Heart Disease academic.oup.com/ajh/article…

Geographical Differences in Hydrochlorothiazide Associated Risk of Skin Cancer Balanced Against...

AbstractBACKGROUND. Hypertension affects 25%–30% of the world population. Hydrochlorothiazide (HCTZ) is among the most used and cheapest medications but wa

academic.oup.com
4
8
390
Nice to hear about our acceptance to present our late results on IP2015 effects in vascular female peripheral measurements for female sexual dys/function in December @2024_ISRA Thanks for the collaboration @UCV_Noticias @Geomar_Seijas @UsUlf @AarhusUni linkedin.com/feed/update/urn…

#isra2024 | Simon G. Comerma Steffensen

Outstanding to hear that our work with IP2015 (Pudafensine), and its peripheral vascular/flow increments in measured peripheral genitalia of female rats, have been accepted for an oral presentation...

linkedin.com
1
1
93
simoncomerma retweeted
ISRA 2024@2024_ISRA
7 Oct 2024
#ISRA2024 covers a wide range of topics within vascular research!🩺 We have 11 different session topics and 35 oral presentation slots, each 20 minutes long, which will be selected from abstracts! Submit your abstract NOW! The deadline is October 9th at 23:59 CET. ⏰
0:11
1
4
7
1,380
Load more